(Q39953619)

English

Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-β levels and modulates the co-expression between collagen III and α-smooth muscle actin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-β levels and modulates the co-expression between collagen III and α-smooth muscle actin (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Carla Castiglia Gonzaga

2

0 references

author name string

Allan Fernando Giovanini

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

João Cesar Zielak

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Tatiana Miranda Deliberador

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Juliane Kuczera

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Isabella Göringher

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Marco Antonio de Oliveira Filho

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Flares Baratto-Filho

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Cícero Andrade Urban

9

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

4 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Journal of Orthopaedic Research

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

457-463

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Platelet-rich plasma: evidence to support its use.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Platelet-rich plasma: ready or not?

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

The biology of platelet-rich plasma and its application in oral surgery: literature review

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Lack of beneficial effects of platelet-rich plasma on sinus augmentation using a fluorohydroxyapatite or autogenous bone: an explorative study.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Latent TGF-beta1 activation by platelets

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

The logic of TGFbeta signaling.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

TGF-beta and fibrosis in different organs - molecular pathway imprints

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Role of cell shape in growth control

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Myofibroblast and alpha 1 (III) collagen expression in experimental tubulointerstitial nephritis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

The myofibroblast: one function, multiple origins

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

The myofibroblast: paradigm for a mechanically active cell

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Cellular and molecular mechanisms of fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

TGF-beta signaling and the fibrotic response

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Mechanisms of fibrogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Fibrogenesis of parenchymal organs

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

The myofibroblast in pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Scleroderma: from cell and molecular mechanisms to disease models

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

The role of matrix stiffness in regulating cell behavior

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions

1 reference

https://api.crossref.org/works/10.1002%2FJOR.21263

21 January 2018

Identifiers

10.1002/JOR.21263

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39953619&oldid=1880863214"